Evaluating a new laser treatment for skin cancer in veterans
Official title: Safety Assessment of Laser Activated NanoTherapy (LANT) as a Potential Treatment for Veterans with Cutaneous Squamous Cell Carcinomas
Funded at Veterans Health Administration · NIH-10975912 · Data updated 2026-11-12
This study is testing a new treatment called Laser-Activated NanoTherapy for veterans with skin cancer, aiming to safely shrink tumors without surgery, especially for those who can't have traditional treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Administration NIH-funded |
| Lab location | 1 site (Decatur, UNITED STATES) |
| Project start | October 1, 2022 |
| Project end | March 31, 2027 |
| Funding year | 2024 |
| NIH project number | 5I01CX002353-03 |
| Project ID | NIH-10975912 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are veterans diagnosed with cutaneous squamous cell carcinomas who are seeking non-surgical treatment options.
✕Less likely to help
Patients with cSCC who are eligible for surgical treatments or those with other types of skin cancers may not benefit from this research.
What this research studies
This research investigates a novel treatment called Laser-Activated NanoTherapy (LANT) for veterans suffering from cutaneous squamous cell carcinomas (cSCC). The approach utilizes near-infrared lasers to activate gold nanoparticles, which generate heat to selectively destroy cancer cells. This method aims to provide an effective non-surgical option for patients who cannot undergo traditional surgical treatments due to various health conditions. The study will assess the safety and effectiveness of this therapy in achieving tumor regression and improving patient outcomes.
Why it matters
Potential benefit: If successful, this research could offer a new, effective treatment option for veterans with cSCC who are not candidates for surgery.
How similar studies have gone: Preliminary studies have shown promising results with similar nanoparticle-based therapies, indicating potential for success in this novel approach.
Where this research is happening
-
Veterans Health Administration
Decatur, United States Active
Researchers
- Principal investigator: Green, Hadiyah-Nicole — Veterans Health Administration
- Study coordinator: Green, Hadiyah-Nicole
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.